with COVID-19, but appeared more effective when used<br/>in combination with other drugs, including ribavirin and<br/>interferon beta-1b'**'“*. The Randomized Evaluation of<br/>COVID-19 Therapy (RECOVERY) trial, a national clin-<br/>ical trial programme in the UK, has stopped treatment<br/>with lopinavir and ritonavir as no significant beneficial<br/>effect was observed in a randomized trial established in<br/>March 2020 with a total of 1,596 patients'“°. Nevertheless,